Haiying Yan

Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Efficacy and safety of intranasal bencycloquidium bromide in nasal symptoms of common cold: a phase 3, multicenter, randomized, double-blind, placebo-controlled trial.

Efficacy and safety of intranasal bencycloquidium bromide in nasal symptoms of common cold: a phase 3, multicenter, randomized, double-blind, placebo-controlled trial.

Journal: QJM : monthly journal of the Association of Physicians

Published: October 15, 2025

A correlation study of serum tumor markers with systemic lupus erythematosus-associated interstitial lung disease.

A correlation study of serum tumor markers with systemic lupus erythematosus-associated interstitial lung disease.

Journal: Frontiers in medicine

Published: January 10, 2025

Efficacy and Safety of WXSH0208 Tablets in Treatment of Acute Uncomplicated Influenza Infection in Adults: A Multicenter Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

Efficacy and Safety of WXSH0208 Tablets in Treatment of Acute Uncomplicated Influenza Infection in Adults: A Multicenter Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

Journal: The Journal of infectious diseases

Published: November 13, 2024

Anxiety and depression status in patients with idiopathic pulmonary fibrosis and outcomes of nintedanib treatment: an observational study.

Anxiety and depression status in patients with idiopathic pulmonary fibrosis and outcomes of nintedanib treatment: an observational study.

Journal: Annals of medicine

Published: April 06, 2024

Body mass index and weight loss as risk factors for poor outcomes in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.

Body mass index and weight loss as risk factors for poor outcomes in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.

Journal: Annals of medicine

Published: February 01, 2024

Involvement of E3 ubiquitin ligase NEDD4-mediated YY1 ubiquitination in alleviating idiopathic pulmonary fibrosis.

Involvement of E3 ubiquitin ligase NEDD4-mediated YY1 ubiquitination in alleviating idiopathic pulmonary fibrosis.

Journal: International journal of biological macromolecules

Published: December 08, 2023

Serum ferritin as a significant biomarker for patients with idiopathic inflammatory myopathy-associated interstitial lung disease: A systematic review and meta-analysis.

Serum ferritin as a significant biomarker for patients with idiopathic inflammatory myopathy-associated interstitial lung disease: A systematic review and meta-analysis.

Journal: Seminars in arthritis and rheumatism

Published: August 21, 2023

Pulmonary aspergillus infection with abnormal imaging successfully treated with omalizumab: A case report.

Pulmonary aspergillus infection with abnormal imaging successfully treated with omalizumab: A case report.

Journal: Medicine

Published: June 16, 2023

Development and Validation of a Diagnostic Nomogram for Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Pneumonia Patients Undergoing Oral Glucocorticoid Treatment.

Development and Validation of a Diagnostic Nomogram for Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Pneumonia Patients Undergoing Oral Glucocorticoid Treatment.

Journal: Infection and drug resistance

Published: November 23, 2022

NEDD4L-induced β-catenin ubiquitination suppresses the formation and progression of interstitial pulmonary fibrosis via inhibiting the CTHRC1/HIF-1α axis.

NEDD4L-induced β-catenin ubiquitination suppresses the formation and progression of interstitial pulmonary fibrosis via inhibiting the CTHRC1/HIF-1α axis.

Journal: International journal of biological sciences

Published: December 17, 2020

Transcription factor YY1 inhibits the expression of THY1 to promote interstitial pulmonary fibrosis by activating the HSF1/miR-214 axis.

Transcription factor YY1 inhibits the expression of THY1 to promote interstitial pulmonary fibrosis by activating the HSF1/miR-214 axis.

Journal: Aging

Published: January 16, 2020

The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy.

The Role of MicroRNAs in the Pathogenesis of Diabetic Nephropathy.

Journal: International journal of endocrinology

Published: August 06, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026